The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: A Retrospective Analysis of the National Cancer Database

Background: Immunotherapy has shown great success in various malignancies. However, its efficacy in pancreatic ductal adenocarcinoma (PDAC) remains a challenge, and the lack of understanding about the appropriate timing of immunotherapy with other standard-of-care cancer treatments may be one of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Saber, Baine, Michael J., Meza, Jane L., Lin, Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492650/
https://www.ncbi.nlm.nih.gov/pubmed/32983998
http://dx.doi.org/10.3389/fonc.2020.01518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492650/
https://www.ncbi.nlm.nih.gov/pubmed/32983998
http://dx.doi.org/10.3389/fonc.2020.01518

Ejemplares similares